Xichun Hu

23PUBLICATIONS
24CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 27, 2026
High-Density Type I Collagen Promotes IFN-γ+ CD8+ T Cell Exhaustion via SAT1-ASS1-Mediated Glutamine Accumulation and Ferroptosis in Triple-Negative Breast Cancer.

|Aug 27, 2026
Prominin 2 promotes the progression of breast cancer by inhibiting ferroptosis via MAPK signaling.

|May 26, 2026
Targeting arginine metabolism reverses bone immunosuppressive microenvironment and metastasis in ARID1A-deficient triple negative breast cancer.

|Nov 20, 2025
Clinical and genomic characteristics of HER2-ultralow breast cancer and implications for T-DXd therapy.

Juan Jin, Tiantian Liu, Mengyuan Cai

|May 09, 2025
Capivasertib plus fulvestrant in patients with HR-positive/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort.

Xichun Hu, Qingyuan Zhang, Tao Sun

|Mar 04, 2025
Ferroptosis-related genes as prognostic markers for survival and immunotherapy in triple-negative breast cancer: analysis of public databases and a single institution.

Yizhao Xie, Zhonghua Tao, Biyun Wang

Pageof 4

Frequent Collaborators

4 joint publications

Biyun Wang

3 joint publications

Zhonghua Tao

2 joint publications

Mengdi Yang

1 joint publications

Zhongyi Yang